September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Combined phaco-vitrectomy for Full Thickness Macular Hole (FTMH) should not considered a risk factor for post-operative Cystoid Macular Oedema (CMO).
Author Affiliations & Notes
  • Thomas Papathomas
    Ophthalmology, Southampton General Hospital, Southampton, United Kingdom
  • Sandro Di Simplicio Cherubini
    Ophthalmology, Southampton General Hospital, Southampton, United Kingdom
  • Yasmine Abdalla
    Ophthalmology, Southampton General Hospital, Southampton, United Kingdom
  • Philip Alexander
    Ophthalmology, Southampton General Hospital, Southampton, United Kingdom
    Moorfields Eye Hospital, London, United Kingdom
  • Stephen Lash
    Ophthalmology, Southampton General Hospital, Southampton, United Kingdom
  • Richard Newsom
    Ophthalmology, Southampton General Hospital, Southampton, United Kingdom
  • Footnotes
    Commercial Relationships   Thomas Papathomas, None; Sandro Di Simplicio Cherubini, None; Yasmine Abdalla, None; Philip Alexander, None; Stephen Lash, None; Richard Newsom, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 4470. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Thomas Papathomas, Sandro Di Simplicio Cherubini, Yasmine Abdalla, Philip Alexander, Stephen Lash, Richard Newsom; Combined phaco-vitrectomy for Full Thickness Macular Hole (FTMH) should not considered a risk factor for post-operative Cystoid Macular Oedema (CMO).. Invest. Ophthalmol. Vis. Sci. 2016;57(12):4470.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate whether concurrent phacoemulcification is increasing the risk for post-operative CMO in patients having vitrectomy and ILM peel for FTMH.

Methods : Retrospective study of patients operated for FTMH having vitrectomy and peel in Southampton University Hospital from March 2010 till April 2015. Data extrapolated from Medisoft and Topcon OCT and included type of operation and pre- and post-operative OCT scans at 2 weeks and 3 months post-vitrectomy.

Results : 411 eyes from 391 patients having vitrectomy and ILM peel for FTMH were included. 318 (77.4%) eyes had concurrent Phaco-IOL. Post-operative CMO was present in total in 16 eyes (3.9%). In the combined Phaco/Vitrectomy group CMO was present in 12 eyes (3.77%), while in the vitrectomy alone group CMO was present in 4 eyes (4.34%). Statistical analysis showed that p value for the presence of CMO between the two groups was 0.802. In all cases CMO resolved with topical treatment with steroidal and non steroidal anti-inflammatory agents. There was no re-opening of macular holes associated with post-operative CMO.

Conclusions : Our study shows that concurrent phacoemulcification in patients having vitrectomy and peel for FTMH does not seem to increase the presence of post-operative CMO and is not associated with re-opening of the macular hole. Prospective studies are required to consider adding non steroidal anti-inflammatory agents to prevent presence of post-operative CMO.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×